Online Inquiry
Cat.#: ACPP-1846
| Despition | FGF 9 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% by RP-HPLC and SDS-PAGE. |
| Form | Sterile Filtered white lyophilized powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1168 | KCNJ5 Blocking Peptide (AC1168) | 250 µg | inquiry |
| ACPP-1785 | Human NEUROG3 Protein (AC1785) | 2 µg | inquiry |
| ACPP-1262 | CXCR4 Blocking Peptide (AC1262) | 250 µg | inquiry |
| ACPP-1669 | Human NRGN Protein (AC1669) | 2 µg | inquiry |
| ACPP-1745 | Mouse Acrp30 Protein, His (AC1745) | 5 µg | inquiry |
| ACPP-1569 | Human SOX2 Protein (AC1569) | 5 µg | inquiry |
| ACPP-1814 | PPA E.Coli (AC1814) | 5 µg | inquiry |
| ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg | inquiry |
| ACPP-1719 | Human FDFT1 Protein (AC1719) | 2 µg | inquiry |
| ACPP-1660 | Mouse GDF7 Protein (AC1660) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.